Parikshit Augmented Generation_VC — 2026-02

Overview

February added 19 items to . The set spans venture market structure, AI-first org design, AI interpretability, biopharma platform strategy, agtech consolidation, and a mix of market data, deals, and long-form reads.

Included articles (added in 2026-02)

• Formation Bio | Building an AI-Native Pharma Company
• Scaling Bio 006: Formation Bio's CTO on Building an AI-Native Pharma
• (1) The Case for Scaling Venture - by Erik Torenberg - a16z
• The Hidden Structure Behind Today’s Fastest Startups
• On the Biology of a Large Language Model
• The Evolution of Photonic Integrated Circuits and Silicon Photonics
• CropX’s roll-up strategy—without the distressed assets
• History for The Nasdaq Veles California Water
• Nebius Group Investor Presentation
• Trump Unveils $12 Billion Critical Minerals Stockpile - The New York Times
• Johnson Controls signs agreement to acquire Alloy Enterprises, strengthening data center thermal management leadership
• Zeon, Visolis sign binding term sheet for FID on isoprene, SAF facility | SAF Investor
• Ex-DeepMind scientist seeks $1bn for ‘superhuman intelligence’ startup | Sifted
• Ten63 Therapeutics Closes Strategic Financing, Bringing Total Funding to More Than $45M to Scale the Next-Generation of Artificial Intelligent Drug Discovery - TEN63
• The $2B Bet Against LLMs: The Biggest Signal in AI This Year
• The $2B Bet Against LLMs: The Biggest Signal in AI This Year